Trustmark National Bank Trust Department’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229K Sell
777
-77
-9% -$22.9K 0.01% 259
2025
Q4
$233K Sell
854
-8
-0.9% -$2.17K 0.01% 265
2025
Q3
$233K Sell
862
-3
-0.3% -$816 0.02% 266
2025
Q2
$238K Sell
865
-211
-20% -$57.4K 0.02% 262
2025
Q1
$285K Buy
+1,076
New +$265K 0.02% 254
2014
Q2
Sell
-2,750
Closed -$204K 342
2014
Q1
$204K Hold
2,750
0.02% 333
2013
Q4
$216K Buy
+2,750
New +$215K 0.03% 312

Other funds holding CME

Trustmark National Bank Trust Department's CME Position: Q1 2026 in Review

Trustmark National Bank Trust Department reduced its CME Group (CME) stake by 9% in Q1 2026, selling an estimated $22.9K and leaving 777 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #259.

Trustmark National Bank Trust Department first reported a position in CME in Q4 2013 and has held it in 7 quarters since. The position peaked at $285K in Q1 2025. 1,796 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Trustmark National Bank Trust Department held 777 shares of CME Group worth $229K as of Q1 2026.
  • Trustmark National Bank Trust Department sold 77 CME Group shares in Q1 2026, an estimated $22.9K.
  • CME Group made up 0.01% of Trustmark National Bank Trust Department's portfolio in Q1 2026, its #259 holding.
  • Trustmark National Bank Trust Department first reported a position in CME Group in Q4 2013 and has held it in 7 quarters since.
  • Trustmark National Bank Trust Department's CME Group position peaked at $285K in Q1 2025.
  • 1,796 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Trustmark National Bank Trust Department's 13F filing for Q1 2026, filed 14 May 2026.